エクソソーム研究市場：動向、機会、競合分析【2023年～2028年】

エクソソーム研究の市場動向と予測

世界のエクソソーム研究市場は、2023年から2028年までのCAGRが33.6%で、2028年までに推定11億6,000万米ドルに達すると予想されています。この市場の主な促進要因は、がん患者の増加、さまざまな病気を治療するための無細胞療法のニーズの高まり、生命科学研究への資金の増加です。世界のエクソソーム研究市場の将来は、学術・研究機関、製薬・バイオテクノロジー企業、病院・臨床検査ラボの各市場でのビジネスチャンスが期待できそうです。

エクソソーム研究企業一覧

市場の企業は、提供する製品の品質に基づいて競争しています。この市場の主要企業は、製造施設の拡大、研究開発投資、インフラ整備、バリューチェーン全体における統合機会の活用に注力しています。これらの戦略により、エクソソーム研究企業は需要の増加に対応し、競争力を確保し、革新的な製品と技術を開発し、生産コストを削減し、顧客基盤を拡大しています。

エクソソーム研究の市場洞察

• Lucintelは、細胞外小胞の単離という面倒なプロセスを省くことができるキット・試薬が、予測期間中、最大のセグメントであり続けると予測しています。
• この市場において、学術・研究機関は、エクソソームが疾病診断に役立つこと、細胞間メッセンジャーとしての新たな役割を担うことから、近年エクソソーム研究の需要が増加しており、引き続き最大のセグメントとなると予想されます。
• 北米は、バイオサイエンス研究への資金提供という形で政府別支援が充実していること、診断や研究所のための高度なインフラがこの地域に存在することから、予測期間中も最大のセグメントであり続けると予想されます。

本レポートでは、以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.どの地域がより速いペースで成長すると思うか、またその理由は？
• Q.4.市場力学に影響を与える主要因は何か？この市場における主な課題とビジネスリスクは何か？
• Q.5.この市場におけるビジネスリスクと競合の脅威は何か？
• Q.6.この市場における新たな動向とその理由は何か？
• Q.7.この市場における顧客の要求の変化にはどのようなものがあるか？
• Q.8.市場における新たな開発は何か？これらの開発をリードしているのはどの企業か？
• Q.9.この市場における主要なプレーヤーは誰か？主要プレーヤーは事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替別市場シェア損失の脅威はどの程度あるのか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のエクソソーム研究市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の推進力と課題

第3章 2017年から2028年までの市場動向と予測分析

• マクロ経済動向（2017～2022年）と予測（2023～2028年）
• 世界のエクソソーム研究市場動向（2017-2022）と予測（2023-2028）
• 製品・サービス別の世界のエクソソーム研究市場
  • キット・試薬
  • 機器
  • サービス
• 適応症別の世界のエクソソーム研究市場
  • がん
  • 神経変性疾患
  • 心血管疾患
  • 感染症
  • その他
• アプリケーション別の世界のエクソソーム研究市場
  • バイオマーカー
  • ワクチン開発
  • 組織の再生
  • その他
• 最終用途別の世界のエクソソーム研究市場
  • 学術調査機関
  • 製薬・バイオテクノロジー企業
  • 病院・臨床検査研究所

第4章 2017年から2028年までの地域別の市場動向と予測分析

• 地域別のエクソソーム研究市場
• 北米のエクソソーム研究市場
• 欧州のエクソソーム研究市場
• アジア太平洋のエクソソーム研究市場
• その他の地域のエクソソーム研究市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品・サービス別の世界のエクソソーム研究市場の成長機会
  • 適応症別の世界のエクソソーム研究市場の成長機会
  • アプリケーション別の世界のエクソソーム研究市場の成長機会
  • 最終用途別の世界のエクソソーム研究市場の成長機会
  • 地域別の世界のエクソソーム研究市場の成長機会
• 世界のエクソソーム研究市場における新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のエクソソーム研究市場の能力拡大
  • 世界のエクソソーム研究市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業プロファイル

• Thermo Fisher Scientific
• Bio-Techne Corporation
• QIAGEN
• System Biosciences
• Miltenyi Biotec
• NanoSomiX
• NorgenBiotek Corp.
• AMS Biotechnology
• Lonza

Exosome Research Market Trends and Forecast

The future of the global exosome research market looks promising with opportunities in the academic & research institute, pharmaceutical & biotechnology companies, and hospital & clinical testing laboratory markets. The global exosome research market is expected to reach an estimated $1.16 billion by 2028 with a CAGR of 33.6% from 2023 to 2028. The major drivers for this market are increasing number of cancer patients, growing need for cell-free therapies to treat variety of diseases, and rising funds for life sciences research.

A more than 150-page report is developed to help in your business decisions.

Exosome Research Market by Segment

The study includes a forecast for the global exosome research market by product & service, indication, application, end use, and region, as follows:

Exosome Research Market by Product & Service [Value ($B) Shipment Analysis from 2017 to 2028]:

• Kits & Reagents
• Instruments
• Services

Exosome Research Market by Indication [Value ($B) Shipment Analysis from 2017 to 2028]:

• Cancer
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Others

Exosome Research Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

• Biomarkers
• Vaccine Development
• Tissue Regeneration
• Others

Exosome Research Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospital & Clinical Testing Laboratories

Exosome Research Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Exosome Research Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies exosome research companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the exosome research companies profiled in this report include.

• Thermo Fisher Scientific
• Bio-Techne Corporation
• QIAGEN
• System Biosciences
• Miltenyi Biotec
• NanoSomiX
• NorgenBiotek Corp.
• AMS Biotechnology
• Lonza

Exosome Research Market Insights

• Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period because it helps in eliminating the tedious process of isolation of extracellular vesicles.
• Within this market, academic & research institutes are expected to remain the largest segment due to their capability of disease diagnosis and emerging role as an intercellular messengers, has resulted in an increase in demand for exosome study in recent years.
• North America is expected to remain the largest segment during the forecast period due to favorable government support in the form of funding for bio sciences research and presence of advanced infrastructure for diagnostic and lab research in the region.

Features of the Exosome Research Market

• Market Size Estimates: Exosome research market size estimation in terms of value ($B)
• Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
• Segmentation Analysis: Exosome research market size by various segments, such as by product & service, indication, application, end use, and region
• Regional Analysis: Exosome research market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different by product & service, indication, application, end use, and regions for the exosome research market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the exosome research market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the exosome research market size?

Answer: The global exosome research market is expected to reach an estimated $1.16 billion by 2028.

Q2. What is the growth forecast for exosome research market?

Answer: The global exosome research market is expected to grow with a CAGR of 33.6% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the exosome research market?

Answer: The major drivers for this market are increasing number of cancer patients, growing need for cell-free therapies to treat variety of diseases, and rising funds for life sciences research.

Q4. What are the major segments for exosome research market?

Answer: The future of the exosome research market looks promising with opportunities in the academic & research institute, pharmaceutical & biotechnology companies, and hospital & clinical testing laboratory markets.

Q5. Who are the key exosome research companies?

Answer: Some of the key exosome research companies are as follows:

• Thermo Fisher Scientific
• Bio-Techne Corporation
• QIAGEN
• System Biosciences
• Miltenyi Biotec
• NanoSomiX
• NorgenBiotek Corp.
• AMS Biotechnology
• Lonza

Q6. Which exosome research segment will be the largest in future?

Answer:Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period because it helps in eliminating the tedious process of isolation of extracellular vesicles.

Q7. In exosome research market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to remain the largest segment during the forecast period due to favourable government support in the form of funding for bio sciences research and presence of advanced infrastructure for diagnostic and lab research in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the exosome research market by product & service (kits & reagents, instruments, and services), indication (cancer, neurodegenerative diseases, cardiovascular disease, infectious diseases, and others), application (biomarkers, vaccine development, tissue regenerative, and others), end use industry (academic & research institutes, pharmaceutical & biotechnology companies, and hospital & clinical testing laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

Table of Contents

1. Executive Summary

2. Global Exosome Research Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1. Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2. Global Exosome Research Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Exosome Research Market by Product & Service
  • 3.3.1 Kits & Reagents
  • 3.3.2 Instruments
  • 3.3.3 Services
• 3.4: Global Exosome Research Market by Indication
  • 3.4.1 Cancer
  • 3.4.2 Neurodegenerative Diseases
  • 3.4.3 Cardiovascular Diseases
  • 3.4.4 Infectious Diseases
  • 3.4.5 Others
• 3.5: Global Exosome Research Market by Application
  • 3.5.1 Biomarkers
  • 3.5.2 Vaccine Development
  • 3.5.3 Tissue Regeneration
  • 3.5.4 Others
• 3.6: Global Exosome Research Market by End Use
  • 3.6.1 Academic & Research Institutes
  • 3.6.2 Pharmaceutical & Biotechnology Companies
  • 3.6.3 Hospital & Clinical Testing Laboratories

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Exosome Research Market by Region
• 4.2: North American Exosome Research Market
  • 4.2.1: North American Exosome Research Market by Product & Service: Kits & Reagents, Instruments, and Services
  • 4.2.2: North American Exosome Research Market by End Use: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospital & Clinical Testing Laboratories
• 4.3: European Exosome Research Market
  • 4.3.1: European Exosome Research Market by Product & Service: Kits & Reagents, Instruments, and Services
  • 4.3.2: European Exosome Research Market by End Use: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospital & Clinical Testing Laboratories
• 4.4: APAC Exosome Research Market
  • 4.4.1: APAC Exosome Research Market by Product & Service: Kits & Reagents, Instruments, and Services
  • 4.4.2: APAC Exosome Research Market by End Use: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospital & Clinical Testing Laboratories
• 4.5: ROW Exosome Research Market
  • 4.5.1: ROW Exosome Research Market by Product & Service: Kits & Reagents, Instruments, and Services
  • 4.5.2: ROW Exosome Research Market by End Use: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Hospital & Clinical Testing Laboratories

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Exosome Research Market by Product & Service
  • 6.1.2: Growth Opportunities for the Global Exosome Research Market by Indication
  • 6.1.3: Growth Opportunities for the Global Exosome Research Market by Application
  • 6.1.4: Growth Opportunities for the Global Exosome Research Market by End Use
  • 6.1.5: Growth Opportunities for the Global Exosome Research Market by Region
• 6.2: Emerging Trends in the Global Exosome Research Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Exosome Research Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Exosome Research Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Bio-Techne Corporation
• 7.3: QIAGEN
• 7.4: System Biosciences
• 7.5: Miltenyi Biotec
• 7.6: NanoSomiX
• 7.7: NorgenBiotek Corp.
• 7.8: AMS Biotechnology
• 7.9: Lonza